Phase I trial of CH 4051 in volunteers.

Trial Profile

Phase I trial of CH 4051 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2010

At a glance

  • Drugs CH 4051 (Primary)
  • Indications Arthritis; Rheumatoid arthritis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 27 Sep 2010 Status changed from recruiting to completed, according to a Chelsea Therapeutics media release.
    • 03 Nov 2009 Results presented at 2009 Annual Scientific Meeting of the American College of Rheumatology.
    • 21 Oct 2009 Results were presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals (ACR/ARHP-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top